Results 281 to 290 of about 216,038 (323)
Some of the next articles are maybe not open access.
[Andrological testosterone replacement therapy].
Der Urologe. Ausg. A, 2009Male hypogonadism is characterised by decreased testicular function, especially testosterone deficiency. Its prevalence increases with age but may be acquired in all stages of life if it is not inborn. The lack of testosterone results in typical clinical symptoms. However, only about 10% of the affected men currently receive adequate treatment.
U, Paasch +2 more
openaire +1 more source
Testosterone Replacement Therapy and Prostate Cancer
Urologic Clinics of North America, 2007The long-standing concern that testosterone replacement therapy (TRT) may increase the risk of prostate cancer (PCa) has come under new scrutiny. Arguments used to support this concern lack a scientific basis. The original assertion by Huggins that administration of testosterone (T) caused "enhanced growth" of PCa was based on only a single patient ...
openaire +2 more sources
Testosterone Replacement Therapy in Orthopaedic Surgery
Journal of the American Academy of Orthopaedic SurgeonsTestosterone replacement therapy (TRT) is an indicated treatment of several medical conditions including late-onset hypogonadism, congenital syndromes, and gender affirmation hormonal therapy. Increasing population age, medical benefits, and public awareness of TRT have resulted in increased prevalence of its utilization.
Randy M. Cohn +2 more
openaire +2 more sources
Testosterone replacement therapy and cardiovascular events
BMJ, 2014In February 2014, The BMJ published a personal view by Sidney Wolfe of Public Citizen—a US anti-pharmaceutical pressure group trying to obtain black box warnings for testosterone products.1 The article presented summaries from two recent papers that claimed increased cardiovascular risk with testosterone replacement therapy (TRT).2 3 In July 2014, the
openaire +2 more sources
Radiation therapy‐associated toxicity: Etiology, management, and prevention
Ca-A Cancer Journal for Clinicians, 2021Kyle Wang
exaly
[Testosterone replacement therapy and cardiovascular risk].
Giornale italiano di cardiologia (2006), 2017Late onset hypogonadism (LOH) is the most commonly used term to indicate the age-dependent reduction of testosterone. Sexual dysfunction represents the most important determinant for medical consultation and the most specific symptoms associated with LOH.
Giovanni Corona +4 more
openaire +2 more sources
Testosterone replacement therapy
Cardiovascular Endocrinology, 2015Vijaya Surampudi, Ronald S. Swerdloff
openaire +1 more source